Adaptive Biotechnologies (ADPT) total assets

Total assets · fiscal 2025
$512.74M

Adaptive Biotechnologies (ADPT) had total assets of $512.74M at the end of fiscal 2025 (December 31, 2025). That is 4.9% lower than the $539.38M of fiscal 2024. Figures as of 18 Nov 2026, 04:59 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$512.74M
Change on fiscal 2024
−4.9%
Growth, 5 years
−14.4% a year
Highest on record
$1.12Bfiscal 2020
Lowest on record
$332.69Mfiscal 2018
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Adaptive Biotechnologies total assets, in more detail

Over the five fiscal years to 2025 total assets shrank at a compound 14.4% a year. Across the 8 fiscal years on record (2018–2025), the highest was $1.12B in fiscal 2020 and the lowest $332.69M in fiscal 2018.

History · 8 fiscal years

Total assets by fiscal year

Adaptive Biotechnologies total assets, year by year

Adaptive Biotechnologies (ADPT) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$512.74M 4.9% down
2024$539.38M 18.4% down
2023$661.13M 22.8% down
2022$856.62M 7.2% down
2021$923.34M 17.3% down
2020$1.12B 22.4% up
2019$912.30M 174.2% up
2018$332.69M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Adaptive Biotechnologies and comparable companies
CompanyTotal assetsFiscal year
Dianthus Therapeutics DNTH$530.92M2025
MiniMed Group MMED$4.63B2026
Adaptive Biotechnologies ADPT$512.74M2025
Heartflow HTFL$359.45M2025
CRISPR Therapeutics CRSP$2.27B2025
Travere Therapeutics TVTX$605.19M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ADPT

Adaptive Biotechnologies, figure by figure

Adaptive Biotechnologies (ADPT) overview: price, valuation and scorecardAll health care companies by market value

Adaptive Biotechnologies total assets: questions and answers

How large are Adaptive Biotechnologies's total assets?

Adaptive Biotechnologies (ADPT) had total assets of $512.74M at the end of fiscal 2025 (December 31, 2025). That is 4.9% lower than the $539.38M of fiscal 2024.

What is the growth rate of Adaptive Biotechnologies's total assets?

Over the five fiscal years to 2025 total assets shrank at a compound 14.4% a year.

What are the highest and lowest total assets figures on record for Adaptive Biotechnologies?

Across the 8 fiscal years on record (2018–2025), the highest was $1.12B in fiscal 2020 and the lowest $332.69M in fiscal 2018.

How is Adaptive Biotechnologies's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Adaptive Biotechnologies (ADPT) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/ADPT/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.